Trial Site Detail
Drug: |
Masitinib, (AB1010) |
|||
|---|---|---|---|---|
Trial: |
A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
St. Luke’s Cancer Center801 Ostrum Street |
Principal Investigator: |
Sanjiv Agarwala |
|---|---|
Contact: |
|
Activation Status of this Site: |
Active |
Notes about this Site: |
|
St. Luke’s Cancer Center
Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.